Intravenous Brain-Derived Neurotrophic Factor Reduces Infarct Size and Counterregulates Bax and BCL-2 Expression After Temporary Focal Cerebral Ischemia Editorial Comment
Stroke - United States
doi 10.1161/01.str.31.9.2212
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2000
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)